--- title: "Semaglutide Drug Class India" description: "Semaglutide drug class in India: CDSCO-approved injectable and oral forms, titration, cost, safety, generics, and RSSDI prescribing without brand promotion." canonical: "https://www.kesho.health/keywords/ozempic-class-india" markdown_url: "https://www.kesho.health/md/keywords/ozempic-class-india" language: "en-IN" primary_keyword: "semaglutide India drug class" --- # Semaglutide drug class in India — complete overview > **Short answer:** Semaglutide is a GLP-1 receptor agonist molecule available as weekly injectable pens and daily oral tablets in CDSCO-approved Schedule H formulations across Indian pharmacies. Kesho educates on the semaglutide drug class—including generics and titration—not innovator brand marketing names popular on social media. **Canonical HTML:** https://www.kesho.health/keywords/ozempic-class-india **Markdown:** https://www.kesho.health/md/keywords/ozempic-class-india ## Weekly injectable class **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **Monthly budget worksheet** — Plan medicine, labs, consultations, and travel costs for 12–24 months of GLP-1 therapy in India. [Monthly budget worksheet](https://www.kesho.health/glp-1-budget-worksheet) ## What is semaglutide as a GLP-1 drug class? Semaglutide activates GLP-1 receptors to improve glycaemic control, reduce appetite, and support weight management in approved indications—available as weekly subcutaneous injections and oral tablets in India under CDSCO regulation. The molecule defines the drug class; multiple CDSCO-approved manufacturers market generic and innovator products under different trade names. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What indications do CDSCO labels cover for semaglutide? CDSCO-approved semaglutide products specify diabetes and obesity indications per individual product labels—physicians match prescriptions to labelled uses with Schedule H documentation. Off-label social-media claims about cosmetic weight loss bypass contraindication screening required for safe prescribing under RSSDI norms. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How does semaglutide titration work for injectable pens? Weekly injectable semaglutide begins at lowest labelled doses for four or more weeks before escalation—reducing nausea while building therapeutic exposure. Missed-dose rules follow CDSCO insert language; never double injections without prescriber confirmation. Home injection training from clinic nurses supports tier-2 patients starting therapy. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What safety warnings apply across semaglutide products? Pancreatitis precautions, medullary thyroid carcinoma and MEN2 contraindications, pregnancy exclusions, and gastroparesis caution apply to all semaglutide formulations—injectable and oral. Report severe abdominal pain, neck lumps, or persistent vomiting urgently. Kesho safety guide expands thyroid and side-effect detail with references. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How much does semaglutide cost across Indian metros? Maintenance-dose injectable semaglutide typically ranges ₹7,500–₹18,000 monthly in 2026 metro surveys—generics toward lower bands. Oral semaglutide often parallels injection pricing. Twenty-four-month budgets include titration months, consultations, quarterly HbA1c labs, and sharps disposal beyond pen line items alone. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How do semaglutide generics work in India? CDSCO-approved generic semaglutide from Indian manufacturers contains the same molecule as innovator pens when verified at licensed pharmacies—often saving ₹2,000–₹5,000 monthly. Match prescription molecule names to package inserts; reject grey-market products lacking Schedule H traceability per March 2026 advisory enforcement. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How does semaglutide compare with tirzepatide? Tirzepatide dual GIP/GLP-1 agonism differs mechanistically from semaglutide GLP-1 selectivity—physicians choose based on clinical response, tolerability, and affordability rather than ranking claims. Semaglutide generally costs less monthly at Indian retail. Kesho comparison guide expands trial context without brand promotion. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What lifestyle pairing does RSSDI expect with semaglutide? ICMR and RSSDI emphasise structured nutrition, physical activity, and behavioural support alongside semaglutide pharmacotherapy—not pen-only approaches during festival and wedding seasons. Thin-fat South Asian patients need waist tracking alongside scale weight during therapy monitoring at quarterly follow-up visits. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Where is the full semaglutide India guide on Kesho? Our cornerstone semaglutide guide expands CDSCO verification, oral versus injectable rules, cost tables, safety data, and doctor-preparation checklists with PubMed references. This landing orients semaglutide drug-class search intent without innovator trademark promotion. Schedule H licensed pharmacies only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Quick questions ### Is Semaglutide Drug Class India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on semaglutide drug class india? Semaglutide is a GLP-1 receptor agonist molecule available as weekly injectable pens and daily oral tablets in CDSCO-approved Schedule H formulations across Indian pharmacies. Kesho educates on the semaglutide drug class—including generics and titration—not innovator brand marketing names popular on social media. ## Complete guide [semaglutide-india-complete-guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) · [MD](https://www.kesho.health/md/blog/semaglutide-india-complete-guide) ## Related guides - [Semaglutide Cost Mumbai](https://www.kesho.health/keywords/semaglutide-cost-mumbai) - [Oral Semaglutide in India](https://www.kesho.health/keywords/oral-semaglutide-india) - [Is Semaglutide Safe in India? What Patients Should Know](https://www.kesho.health/blog/is-semaglutide-safe-india) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*